Ipca Laboratories Ltd

NSE: IPCALAB · BSE: 524494 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹1,938.40
Market cap: ₹49,178 Cr
Revenue (annual): ₹9,646 Cr
Net profit (annual): ₹1,141 Cr
P/E (TTM): 35.1×Sector 43.8×
Promoter holding: 44.72%+0.00% QoQ
FII holding: 11.53%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Earnings Call 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

6 Nov 2026 17:31 IST BSE

Earnings Call

Ipca Laboratories Earnings Call Transcript: Key Takeaways

Consolidated sales rose about 14% to ₹2,910 Cr and EBITDA margin reached 22.97%, inside the 22-23% guided band. Management reiterated FY27 guidance without a raise.

Open call summary → Read the filing ↗

5 Nov 2026 13:42 IST NSE

Financial Results

Ipca Laboratories Q2 FY27 Results: Net Profit ₹389.3 Cr, Up 38.8% YoY

Ipca Laboratories Ltd reported revenue from operations of ₹2,910 Cr (+13.8% YoY) and net profit of ₹389.3 Cr (+38.8% YoY) for Q2 FY27.

Key figure: Net profit ₹389.3 Cr · +38.8% YoY

Open full results → Read the filing ↗